Clinical trial
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
NCT00239135 · Peplin, Industry · Completed
Key facts
| NCT number | NCT00239135 |
|---|---|
| Title | Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel |
| Official title | An Open-label, Dose Escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel When Applied on Day 1 and Day 2 to Actinic Keratoses on the Shoulders, Chest, Back or Arms Followed by a Post-Treatment Follow-up Period Lasting at Four Weeks |
| Lead sponsor | Peplin, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Keratosis |
| Intervention type | Drug |
| Interventions | PEP005 |
| Enrollment | 34 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 14, 2005 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: